PsyBio Therapeutics Corp. announced the addition of life sciences veteran Ian Wisenberg to the Company's board of directors (the "Board") and as an independent member of the Company's audit committee. Mr. Wisenberg's career spans over three decades in biotechnology international business with an emphasis in finance, capital formation, corporate and business development.

Ian has been an integral leader charting innovation and growth across several Bridgewest Group biotech companies. As CEO and board director of BioCina Pty Ltd., he leads a highly accomplished team, recognized for its strong history as a multi-product biologics development and manufacturing. Prior to taking the helm at BioCina, Ian was founder and Chief Business Officer of BioArdis, Chief Financial Officer at BioDuro and previous to these roles ran a very successful global life sciences consulting practice, BioGlobal Consulting Group, which had an extensive client list of biotech and pharma companies in the USA and abroad.

Ian is from Cape Town, South Africa, and attended the University of Cape Town.